Bharat Immunologicals & Biologicals Corporation Limited

Bharat Immunologicals & Biologicals Corporation Limitedverified

BIBCL.BO

Price:

$18.89

Market Cap:

$815.54M

Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. It operates through the following business segments: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. The company was founded on March 10, 1989 and is headquartered in Bulandshahr, India.

Industry

Medical - Pharmaceuticals

IPO Date

Stock Exchange

BSE

Ticker

BIBCL.BO

The PE Ratio as of December 2025 (TTM) for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) is -5.01

According to Bharat Immunologicals & Biologicals Corporation Limited’s latest financial reports and current stock price. The company's current PE Ratio is -5.01. This represents a change of -23.00% compared to the average of -6.51 of the last 4 quarters.

Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) Historical PE Ratio (quarterly & annually)

How has BIBCL.BO PE Ratio performed in the past?

The mean historical PE Ratio of Bharat Immunologicals & Biologicals Corporation Limited over the last ten years is 4.98. The current -5.01 PE Ratio has changed -10154.85% with respect to the historical average. Over the past ten years (40 quarters), BIBCL.BO's PE Ratio was at its highest in in the December 2018 quarter at 699.61. The PE Ratio was at its lowest in in the December 2021 quarter at -182.66.

Quarterly (TTM)
Annual

Average

4.98

Median

-6.32

Minimum

-20.06

Maximum

101.67

Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bharat Immunologicals & Biologicals Corporation Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.64%

Maximum Annual PE Ratio = 101.67

Minimum Annual Increase = -233.84%

Minimum Annual PE Ratio = -20.06

Quarterly (TTM)
Annual
YearPE RatioChange
2023-5.76-58.46%
2022-13.8627.79%
2021-10.85340.74%
2020-2.46-64.19%
2019-6.87-65.74%
2018-20.06-233.84%
201714.99-216.82%
2016-12.83-112.62%
2015101.671.64%
20145.86-46.18%

Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) Average PE Ratio

How has BIBCL.BO PE Ratio performed in the past?

The current PE Ratio of Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-10.16

5-year avg

-7.96

10-year avg

4.98

Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) PE Ratio vs. Peers

How is BIBCL.BO’s PE Ratio compared to its peers?

Bharat Immunologicals & Biologicals Corporation Limited’s PE Ratio is less than Welcure Drugs & Pharmaceuticals Limited (1.77), less than Source Natural Foods and Herbal Supplements Limited (29.18), greater than Makers Laboratories Limited (-3302.05), less than Sunil Healthcare Limited (41.55), less than Kretto Syscon Limited (8.88), less than Transchem Limited (50.30), greater than Jeevan Scientific Technology Limited (-23.41), less than Mercury Laboratories Limited (26.59), less than Raaj Medisafe India Limited (11.47), less than Concord Drugs Limited (149.58),

Build a custom stock screener for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bharat Immunologicals & Biologicals Corporation Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bharat Immunologicals & Biologicals Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bharat Immunologicals & Biologicals Corporation Limited's PE Ratio?

How is the PE Ratio calculated for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)?

What is the highest PE Ratio for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)?

What is the 3-year average PE Ratio for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)?

What is the 5-year average PE Ratio for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)?

How does the current PE Ratio for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) compare to its historical average?